Company intelligence / Profile preview

Sorokas

Be'er Sheva, Southern District, Israelsorokas.com ↗

Ownership: Private
Development stage: Other

Overview

The Phase I unit at Soroka Clinical Research Center will open in 2025 to facilitate early-stage investigations of new medical interventions. The center has experience as a top recruiting site for major global pharmaceutical and biotech companies across multiple therapeutic areas.

Modalities: Small moleculeBiologicDevice
Industry: Contract Research Organization

Partnerships

Ben-Gurion University of the NegevBGN TechnologiesRosetrees TrustGE HealthcareTEVAMedtronicNovartisAbbVieSanofiMSD/Merck & Co.PfizerEli LillyPPD (Thermo Fisher Scientific)IQVIA Biotech (IQVIA Inc.)PRA Health Sciences (IQVIA Inc.)CATO SMS (CATO Group BV)Perfection Ltd.Covance (Labcorp Drug Development)Parexel International Corp.

Beyond the preview

Go deeper on Sorokas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorokas.

Explore the full profile